Platelet-to-high-density lipoprotein ratio predicts postoperative overall survival in hepatocellular carcinoma: a retrospective cohort study.
[BACKGROUND] The prognostic value of the Platelet-to-High-Density Lipoprotein Ratio (PHR) in HCC patients who underwent hepatectomy remains unclear.
- p-value P = 0.013
- 95% CI 0.43–0.91
- 연구 설계 cohort study
APA
Tang X, Zhang LY, et al. (2026). Platelet-to-high-density lipoprotein ratio predicts postoperative overall survival in hepatocellular carcinoma: a retrospective cohort study.. World journal of surgical oncology, 24(1). https://doi.org/10.1186/s12957-026-04249-y
MLA
Tang X, et al.. "Platelet-to-high-density lipoprotein ratio predicts postoperative overall survival in hepatocellular carcinoma: a retrospective cohort study.." World journal of surgical oncology, vol. 24, no. 1, 2026.
PMID
41731593
Abstract
[BACKGROUND] The prognostic value of the Platelet-to-High-Density Lipoprotein Ratio (PHR) in HCC patients who underwent hepatectomy remains unclear. This study aims to explore the clinical association between PHR and HCC, as well as the prognostic value of PHR in HCC patients after hepatectomy.
[MATERIALS AND METHODS] This retrospective cohort study included 446 HCC patients who underwent curative-intent hepatectomy. The association between PHR and overall survival (OS) was analyzed using Kaplan-Meier and Cox regression methods. A prognostic nomogram incorporating PHR was developed and validated internally.
[RESULTS] Different levels of PHR show a significant correlation with the clinicopathological characteristics of HCC. Preoperative low PHR is associated with better overall survival (OS) (Hazard Ratio [HR]: 0.63, 95% CI: 0.43–0.91, P = 0.013) in post-hepatectomy HCC patients, and the nomogram incorporating PHR demonstrates a modest net benefit in predicting OS.
[CONCLUSION] The PHR could independently predict HCC OS after hepatectomy. The nomogram incorporating the PHR may aid in the prognostic management of HCC.
[MATERIALS AND METHODS] This retrospective cohort study included 446 HCC patients who underwent curative-intent hepatectomy. The association between PHR and overall survival (OS) was analyzed using Kaplan-Meier and Cox regression methods. A prognostic nomogram incorporating PHR was developed and validated internally.
[RESULTS] Different levels of PHR show a significant correlation with the clinicopathological characteristics of HCC. Preoperative low PHR is associated with better overall survival (OS) (Hazard Ratio [HR]: 0.63, 95% CI: 0.43–0.91, P = 0.013) in post-hepatectomy HCC patients, and the nomogram incorporating PHR demonstrates a modest net benefit in predicting OS.
[CONCLUSION] The PHR could independently predict HCC OS after hepatectomy. The nomogram incorporating the PHR may aid in the prognostic management of HCC.
같은 제1저자의 인용 많은 논문 (5)
- Corrigendum "chemical profiling and investigation of molecular mechanisms underlying anti-hepatocellular carcinoma activity of extracts from Polygonum perfoliatum L." [Biomedicine & Pharmacotherapy 166 (2023) 115315].
- Meta-analytic evaluation of surrogate endpoints at multiple time points in randomized controlled trials with time-to-event endpoints.
- Comments on "Preventive Effect of Helicobacter pylori Treatment on Gastric Cancer Incidence and Mortality: A Korean Population Study".
- Multi-Omics Analysis Reveals DNASE1L3 in Hepatocellular Carcinoma Prognosis, Immune Microenvironment, and Immunotherapy Response.
- Quercetagitrin targets EIF3D to activate NCOA4-mediated ferritinophagy-dependent ferroptosis for the treatment of non-small cell lung cancer.